End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41,500 KRW | +1.34% | +18.57% | +260.87% |
2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Sales * | - | Sales 1 * | - | Capitalization | 130B 95.17M 7.6B |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 0 | Net cash position 1 * | - 0 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | - |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 69.96% |
1 day | +1.34% | ||
1 week | +18.57% | ||
Current month | +21.70% | ||
1 month | +161.01% | ||
3 months | +371.59% | ||
6 months | +453.33% | ||
Current year | +260.87% |
Managers | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 28/03/18 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 30/03/19 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 28/03/18 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 30/03/19 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/03/19 |
Date | Price | Change | Volume |
---|---|---|---|
09/05/24 | 41,500 | +1.34% | 611 315 |
09/05/24 | 40,950 | -0.12% | 842,660 |
08/05/24 | 41,000 | +6.49% | 972,062 |
07/05/24 | 38,500 | +4.76% | 709,896 |
03/05/24 | 36,750 | +5.00% | 1,445,030 |
End-of-day quote Korea S.E., May 09, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+260.87% | 342M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.40% | 32.43B | |
+55.89% | 24.28B | |
-15.96% | 15.52B | |
-41.29% | 12.17B | |
-15.50% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- A304360 Stock